Malpractice issues in radiology. Liability for failure to order screening examinations

American Journal of Roentgenology

Volumn 179, Issue 6, 2002, Pages 1401-1405

  Berlin, Leonard ^a,b  

^a RUSH NORTH SHORE MEDICAL CENTER   (United States)

^b RUSH MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; ARTICLE; BREAST CANCER; CASE REPORT; CLINICAL PRACTICE; DIAGNOSTIC IMAGING; FEMALE; HEALTH CARE QUALITY; HUMAN; IMAGE ANALYSIS; INFORMED CONSENT; LAW SUIT; MALE; MAMMOGRAPHY; MEDICAL DECISION MAKING; MEDICAL LIABILITY; MEDICAL PRACTICE; NEGLIGENCE; PRIORITY JOURNAL; PROSTATE CANCER; RADIOLOGICAL PROCEDURES; RISK MANAGEMENT; BLOOD; BREAST TUMOR; GYNECOLOGY; INTERNAL MEDICINE; LEGAL ASPECT; LEGAL LIABILITY; MALPRACTICE; MIDDLE AGED; PROSTATE TUMOR; RADIOGRAPHY; UNITED STATES;

BREAST NEOPLASMS; FEMALE; GYNECOLOGY; HUMANS; INTERNAL MEDICINE; LIABILITY, LEGAL; MALE; MALPRACTICE; MAMMOGRAPHY; MIDDLE AGED; PENNSYLVANIA; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 0036884936     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/ajr.179.6.1791401     Document Type: Article

References (30)

1. Levine v Rosen, 616 A2d 623 (Pa 1992)
2. Berlin L. Failure to order. AJR 1997;168:19-21
3. Stamey TA, Johnstone IM, McNeal JE, Lu AY, Yemoto CM. Preoperative serum prostate specific antigen levels between 2 and 22 ng./ml. correlate poorly with post-radical prostatectomy cancer morphology: Prostate specific antigen cure rates appear constant between 2 and 9 ng./ml. J Urol 2002;167:103-111
4. Friedrich MJ. Issues in prostate cancer screening. JAMA 1999;281:1573-1575
5. Albertsen P. When is a death from prostate cancer not a death from prostate cancer? J Natl Cancer Inst 2000;92:590-591
6. Wilt TJ. Uncertainty in prostate cancer care: The physician's role in clearing the confusion. JAMA 2000;283:3258-3260
7. Perron L, Moore L, Bairati I, Bernard PM, Meyer F. PSA screening and prostate cancer mortality. Can Med Assoc J 2002;166:586-591
8. Barry MJ. Prostate-specific-antigen testing for early diagnosis of prostate cancer. N Engl J Med 2001;344:1373-1377
9. Vastag B. Study concludes that moderate PSA levels are unrelated to prostate cancer outcomes. JAMA 2002;287:969-970
10. Juffs HG, Tannock IF. Screening trials are even more difficult than we thought they were. J Natl Cancer Inst 2002:94:156-157
11. Novit M. Much better than nothing: Test for prostate cancer isn't perfect but it can signal a problem. Chicago Tribune, Feb 24, 2002:13:3
12. Smith RA, von Eschenbach AC, Wender R, et al. American Cancer Society guidelines for the early detection of cancer: Update of early detection guidelines for prostate, colorectal, and endometrial cancers. CA Cancer J Clin 2001;51:38-75
13. Vis AN. Does PSA screening reduce prostate cancer mortality? Can Med Assoc J 2002; 166:600-601
14. Berlin L. The missed breast cancer: Perceptions and realities. AJR 1999;173:1161-1167
15. Berlin L. Dot size, lead time, fallibility, and impact on survival: Continuing controversies in mammography. AJR 2001;176:1123-1130
16. Berlin L. The missed breast cancer redux: Time for educating the public about the limitations of mammography? AJR 2001;176:1131-1134
17. Crewdson J. In Sweden, decades of mammograms barely cut deaths. Chicago Tribune, Mar 18, 2002:1,7
18. Nystrom L, Andersson I, Bjurstam N, Frisell J, Nordenskjold B, Rutqvist LE. Long-term effects of mammography screening: Updated overview of the Swedish randomised trials. Lancet 2002;359:909-919
19. Gelmon KA, Olivotto I. The mammography screening debate: Time to move on. Lancet 2002;359:904-905
20. U. S. Preventive Services Task Force. Recommendations and Rationale: Screening for Breast Cancer - February 2002. Available at: www.ahcpr.gov/clinic/ 3rduspstf/breastcancer/brcanwh.htm. Accessed February 22, 2002
21. Stolberg SG. Guidelines by U.S. urge mammograms for women at 40. New York Times, Feb 22, 2002:1
22. Peres J. Breast x-rays after 40 urged. Chicago Tribune, Feb 22, 2002:1,2
23. Peres J. Movement to inform women gains momentum. Chicago Tribune, Feb 17, 2002:1:19
24. Welch HG. Informed choice in cancer screening. JAMA 2001:285:2776-2778
25. Wells J, Marshall P, Crawley B, Dickersin K. Newspaper reporting of screening mammography. Ann Intern Med 2001;135:1029-1037
26. Lee TH, Brennan TA. Direct-to-consumer marketing of high-technology screening tests. N Engl J Med 2002;346:529-531
27. Stanley RJ. 2001 ARRS presidential address: Inherent dangers in radiologic screening. AJR 2001;177:989-992
28. Walter LC, Covinsky KE. Cancer screening in elderly patients: A framework for individualized decision making. JAMA 2001:285:2750-2756
29. Berlin L. Liability of performing CT screening for coronary artery disease and lung cancer. AJR 2002;179:837-842
30. American College of Radiology. ACR standard for communication: Diagnostic radiology. In: Standards, 2001-2002. Reston, VA: American College of Radiology, 2001:3-5